En esta página
01IMNM precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
IMNM Immunome, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 11, 2026
$20,90
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$11,55mínimo 52 semanas
$30,06máximo 52 semanas
Capitalización Bursátil (MRQ)
$2.37B
P/E (TTM)
-8.2
BPA (TTM)
$-2.54
Ingresos (TTM)
$0
tus insignias
Rango 52S
$12–$30
Calificación del Analista
BUY
Precio Objetivo
$36
P/E
-8.2
ROE
-64.0%
Margen de Beneficio Neto
-3060.0%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
IMNM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$20.90
Capitalización Bursátil (MRQ)
$2.37B
P/E (TTM)
-8.2
BPA (TTM)
$-2.54
Ingresos (TTM)
$0
ROE (TTM)
-64.0%
Rango 52S
$12–$30
IMNM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$7M2023-12-31 → 2025-12-31
BPA$-2.432020-12-31 → 2025-12-31
Flujo de caja libre$-201M2020-12-31 → 2025-12-31
Margen neto-3060.0%2020-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | IMNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -8.2promedio 5A ≈-3.9 | ≈-3.9 | · | · | |
| P/S | 340.7promedio 5A ≈152.9 | ≈152.9 | 152.8 | Sobrevalorado | |
| P/C (MRQ) | 4.5promedio 5A ≈3.3 | ≈3.3 | 4.5 | Sobrevalorado | |
| Precio / FCF (TTM) | -10.8promedio 5A ≈-16.5 | ≈-16.5 | · | · | |
| Precio / Flujo de Caja (TTM) | -11.4promedio 5A ≈-17.9 | ≈-17.9 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 3.7promedio 5A ≈3.3 | ≈3.3 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | IMNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -3228.8%promedio 5A ≈-98674.5% | ≈-98674.5% | -7718.9% | De primer nivel | |
| EBITDA Margin (Margen EBITDA) | -3193.3%promedio 5A ≈-98485.3% | ≈-98485.3% | -7701.1% | De primer nivel | |
| Net Profit Margin (Margen de Beneficio Neto) | -3060.0%promedio 5A ≈-99574.5% | ≈-99574.5% | -7584.4% | De primer nivel | |
| ROA (TTM) | -59.0%promedio 5A ≈-91.7% | ≈-91.7% | -39.0% | Débil | |
| ROE (TTM) | -64.0%promedio 5A ≈-119.6% | ≈-119.6% | -43.8% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | IMNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 15.1promedio 5A ≈6.9 | ≈6.9 | 14.6 | En línea | |
| Quick Ratio (Ratio Rápido) | 14.5promedio 5A ≈5.9 | ≈5.9 | 10.3 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | IMNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -23.2% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | IMNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.0 | Por debajo del promedio | |
| Revenue / Employee (Ingresos / Empleado) | ≈$28.1K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-1.3%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 19, 2026 | $-0.65 | $-0.53 | -22.0% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.48 | $-0.57 | 16.3% |
| 31 de diciembre de 2025 | $-0.76 | $-0.61 | -23.8% | |
| 30 de septiembre de 2025 | $-0.65 | $-0.59 | -11.0% | |
| 30 de junio de 2025 | $-0.50 | $-0.54 | 7.3% | |
| 31 de marzo de 2025 | $-0.52 | $-0.69 | 25.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $7M | $9M | $14M | |
| R&D Expense | $177M | $130M | $23M | |
| SG&A Expense | $44M | $33M | $20M | |
| Operating Expenses | $231M | $315M | $124M | |
| Operating Income | $-224M | $-306M | $-110M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-212M | $-293M | $-107M | |
| EPS (Basic) | $-2.43 | $-5.00 | $-5.38 | |
| EPS (Diluted) | $-2.43 | $-5.00 | $-5.38 | |
| Shares (Basic) | 87,350,956 | 58,639,441 | 19,843,651 | |
| Shares (Diluted) | 87,350,956 | 58,639,441 | 19,843,651 | |
| EBITDA | $-222M | $-304M | $-109M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $653M | $143M | $99M | |
| Prepaid Expense | $7M | $4M | $7M | |
| Current Assets | $661M | $221M | $145M | |
| PP&E (Net) | $15M | $10M | $2M | |
| Other Non-current Assets | $5M | $4M | $100.0K | |
| Total Assets | $683M | $240M | $149M | |
| Accounts Payable | $3M | $14M | $3M | |
| Current Liabilities | $45M | $54M | $22M | |
| Capital Leases | $4M | $5M | $1M | |
| Deferred Tax | $801.0K | $1M | $378.0K | |
| Other Non-current Liabilities | · | · | $1M | |
| Total Liabilities | $49M | $59M | $29M | |
| Common Stock | $11.0K | $6.0K | $4.0K | |
| Paid-in Capital | $1.36B | $697M | $343M | |
| Retained Earnings | $-728M | $-516M | $-223M | |
| AOCI | $0 | $57.0K | $22.0K | |
| Stockholders' Equity | $634M | $181M | $120M | |
| Liabilities + Equity | $683M | $240M | $149M | |
| Shares Outstanding | 113,133,199 | 64,460,829 | 43,251,778 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $457.0K | |
| Stock-based Comp | $26M | $16M | $6M | |
| Other Non-cash | $-7M | $165M | $93M | |
| Operating Cash Flow | $-191M | $-111M | $-8M | |
| CapEx | $10M | $7M | $831.0K | |
| Investing Cash Flow | $61M | $-85M | $-30M | |
| Stock Issued | $46M | $20M | $34.0K | |
| Net Stock Activity | $46M | $20M | $34.0K | |
| Financing Cash Flow | $640M | $241M | $116M | |
| Net Change in Cash | $510M | $45M | $78M | |
| Free Cash Flow | $-201M | $-118M | $-8M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -3228.8% | -3382.4% | -781.4% | |
| Net Margin | -3060.0% | -3240.4% | -761.9% | |
| EBITDA Margin | -3193.3% | -3365.0% | -778.1% | |
| ROA | -46.0% | -150.7% | -123.8% | |
| ROE | -47.0% | -147.9% | -169.6% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 14.7 | 4.1 | 6.6 | |
| Quick Ratio | 14.5 | 2.6 | 4.5 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.2 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $5.61 | $2.81 | $2.77 | |
| Revenue / Share | $0.08 | $0.15 | $0.71 | |
| Cash Flow / Share | $-2.19 | $-1.89 | $-0.38 | |
| Cash / Share | $5.78 | $2.22 | $2.28 | |
| EPS (TTM) | $-2.43 | $-5.00 | $-5.38 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -23.2% | -35.5% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $7M | $9M | $14M | |
| Net Income TTM | $-212M | $-293M | $-107M | |
| Market Cap | $2.43B | $685M | $463M | |
| P/E | -8.8 | -2.1 | -2.0 | |
| P/S | 350.1 | 75.7 | 33.0 | |
| P/B | 3.8 | 3.8 | 3.9 | |
| P / Tangible Book | 3.8 | 3.8 | 3.9 | |
| P / Cash Flow | -12.7 | -6.2 | -61.2 | |
| P / FCF | -12.1 | -5.8 | -55.1 | |
| Earnings Yield | -11.3% | -47.1% | -50.3% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $4M | $3M | $3M | $3M | $2M | $1M | $4M | $4M | $4M | $2M | |
| R&D Expense | $60M | $46M | $51M | $49M | $40M | $37M | $48M | $37M | $29M | $15M | $10M | $4M | $6M | $4M | |
| SG&A Expense | $18M | $13M | $12M | $11M | $10M | $11M | $10M | $10M | $7M | $6M | $8M | $4M | $4M | $3M | |
| Operating Expenses | $78M | $59M | $73M | $60M | $50M | $48M | $86M | $53M | $42M | $133M | $98M | $8M | $10M | $7M | |
| Operating Income | $-78M | $-59M | $-73M | $-60M | $-46M | $-45M | $-83M | $-51M | $-40M | $-132M | $-95M | $-5M | $-6M | $-4M | |
| Net Income | $-73M | $-54M | $-70M | $-57M | $-43M | $-42M | $-80M | $-47M | $-36M | $-129M | $-93M | $-4M | $-6M | $-4M | |
| EPS (Basic) | $-0.65 | $-0.48 | $-0.76 | $-0.65 | $-0.50 | $-0.52 | $-1.11 | $-0.78 | $-0.60 | $-2.51 | $-4.21 | $-0.36 | $-0.46 | $-0.35 | |
| EPS (Diluted) | $-0.65 | $-0.48 | $-0.76 | $-0.65 | $-0.50 | $-0.52 | $-1.11 | $-0.78 | $-0.60 | $-2.51 | $-4.21 | $-0.36 | $-0.46 | $-0.35 | |
| Shares (Basic) | 113,272,931 | 113,136,836 | · | 87,957,868 | 87,010,742 | 79,410,354 | · | 60,205,327 | 59,936,703 | 51,544,383 | · | 12,202,335 | 12,197,801 | 12,182,478 | |
| Shares (Diluted) | 113,272,931 | 113,136,836 | · | 87,957,868 | 87,010,742 | 79,410,354 | · | 60,205,327 | 59,936,703 | 51,544,383 | · | 12,202,335 | 12,197,801 | 12,182,478 | |
| EBITDA | $-78M | $-59M | · | $-60M | $-46M | $-44M | · | $-51M | $-40M | $-132M | · | $-5M | $-6M | $-4M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $218M | $583M | $653M | $273M | $144M | $258M | $143M | $156M | $165M | $270M | $99M | $91M | $38M | $44M | |
| Prepaid Expense | $18M | $12M | $7M | $7M | $9M | $6M | $4M | $4M | $6M | $4M | $7M | $773.0K | $1M | $2M | |
| Current Assets | $538M | $594M | $661M | $280M | $277M | $323M | $221M | $244M | $284M | $313M | $145M | $91M | $40M | $47M | |
| PP&E (Net) | $17M | $17M | $15M | $12M | $11M | $11M | $10M | $7M | $6M | $4M | $2M | $1M | $1M | $916.0K | |
| Other Non-current Assets | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | $568.0K | $100.0K | · | · | · | |
| Total Assets | $565M | $620M | $683M | $299M | $296M | $343M | $240M | $257M | $296M | $320M | $149M | $93M | $41M | $48M | |
| Accounts Payable | $6M | $6M | $3M | $6M | $5M | $9M | $14M | $4M | $7M | $7M | $3M | $3M | $4M | $3M | |
| Current Liabilities | $36M | $27M | $45M | $31M | $23M | $31M | $54M | $40M | $40M | $31M | $22M | $23M | $26M | $25M | |
| Capital Leases | $5M | $4M | $4M | $4M | $4M | $5M | $5M | $2M | $2M | $1M | $1M | · | · | · | |
| Deferred Tax | · | · | $801.0K | · | · | · | $1M | · | · | · | $378.0K | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $122.0K | · | · | |
| Total Liabilities | $40M | $31M | $49M | $35M | $27M | $36M | $59M | $42M | $42M | $34M | $29M | $87M | $32M | $34M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $9.0K | $9.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.38B | $1.37B | $1.36B | $922M | $870M | $865M | $697M | $650M | $642M | $638M | $343M | $136M | $135M | $134M | |
| Retained Earnings | $-855M | $-782M | $-728M | $-658M | $-601M | $-557M | $-516M | $-436M | $-388M | $-352M | $-223M | $-130M | $-126M | $-120M | |
| AOCI | $-333.0K | · | $0 | $0 | $-24.0K | $-3.0K | $57.0K | $70.0K | $2.0K | $4.0K | $22.0K | · | · | · | |
| Stockholders' Equity | $525M | $589M | $634M | $264M | $269M | $307M | $181M | $215M | $254M | $286M | $120M | $6M | $9M | $14M | |
| Liabilities + Equity | $565M | $620M | $683M | $299M | $296M | $343M | $240M | $257M | $296M | $320M | $149M | $93M | $41M | $48M | |
| Shares Outstanding | 113,399,202 | 113,171,396 | 113,133,199 | 91,706,948 | 87,012,835 | 86,955,855 | 64,460,829 | 60,422,062 | 60,013,655 | 59,694,243 | 43,251,778 | 12,202,516 | 12,200,433 | 12,194,184 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $957.0K | $603.0K | $629.0K | $589.0K | $637.0K | $611.0K | $450.0K | $411.0K | $549.0K | $157.0K | $151.0K | $111.0K | $101.0K | $94.0K | |
| Stock-based Comp | $9M | $8M | $8M | $7M | $5M | $6M | $5M | $5M | $3M | $2M | $3M | $1M | $1M | $1M | |
| Other Non-cash | · | $-13M | · | · | · | $-18M | · | · | · | $116M | · | · | · | $27M | |
| Operating Cash Flow | $-62M | $-59M | $-48M | $-41M | $-49M | $-53M | $-42M | $-34M | $-23M | $-11M | $-17M | $-9M | $-6M | $24M | |
| CapEx | $2M | $3M | $4M | $1M | $905.0K | $4M | $1M | $2M | $2M | $2M | $349.0K | $36.0K | $340.0K | $106.0K | |
| Investing Cash Flow | $-304M | $-12M | $-4M | $124M | $-64M | $5M | $10M | $24M | $-82M | $-37M | $-30M | $-36.0K | $-340.0K | $-106.0K | |
| Stock Issued | · | · | $0 | · | · | · | $20M | · | · | · | $0 | $0 | $0 | $34.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $34.0K | |
| Financing Cash Flow | $1M | $-135.0K | $433M | $45M | $-55.0K | $162M | $20M | $305.0K | $694.0K | $219M | $55M | $61M | $0 | $34.0K | |
| Net Change in Cash | $-365M | $-71M | $381M | $129M | $-114M | $114M | $-12M | $-10M | $-104M | $171M | $8M | $52M | $-6M | $24M | |
| Free Cash Flow | · | $-62M | · | · | · | $-57M | · | · | · | $-13M | · | · | · | $24M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -1157.6% | -1525.5% | · | -1736.1% | -1692.4% | -12857.1% | · | -130.0% | -135.4% | -189.1% | |
| Net Margin | · | · | · | · | -1080.9% | -1423.1% | · | -1618.6% | -1528.0% | -12584.3% | · | -121.9% | -130.4% | -180.6% | |
| EBITDA Margin | · | · | · | · | -1157.6% | -1504.6% | · | -1736.1% | -1692.4% | -12841.8% | · | -130.0% | -135.4% | -185.2% | |
| ROA | -17.0% | -11.2% | · | -20.7% | -14.6% | -12.6% | · | -26.9% | -21.4% | -70.4% | · | -7.0% | -13.8% | -8.9% | |
| ROE | -18.4% | -12.0% | · | -24.0% | -16.6% | -14.1% | · | -42.6% | -27.5% | -86.5% | · | -29.8% | -28.1% | -16.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.1 | 21.7 | · | 8.9 | 12.1 | 10.5 | · | 6.2 | 7.1 | 10.2 | · | 4.0 | 1.5 | 1.9 | |
| Quick Ratio | 6.1 | 21.3 | · | 8.7 | 6.3 | 8.4 | · | 3.9 | 4.1 | 8.8 | · | 3.9 | 1.5 | 1.8 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.63 | $5.20 | · | $2.88 | $3.09 | $3.53 | · | $3.56 | $4.23 | $4.78 | · | $0.50 | $0.77 | $1.14 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.05 | $0.04 | · | $0.05 | $0.04 | $0.02 | · | $0.29 | $0.35 | $0.19 | |
| Cash Flow / Share | · | $-0.52 | · | · | · | $-0.67 | · | · | · | $-0.22 | · | · | · | $1.98 | |
| Cash / Share | $1.92 | $5.15 | · | $2.97 | $1.65 | $2.96 | · | $2.57 | $2.75 | $4.52 | · | $7.43 | $3.15 | $3.64 | |
| EPS (TTM) | $-2.54 | $-2.39 | · | $-2.78 | $-2.91 | $-3.01 | · | $-8.10 | $-7.68 | $-7.54 | · | $-1.81 | $-2.20 | $-2.48 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $4M | · | $10M | $13M | $11M | · | $10M | $11M | $13M | · | · | · | · | |
| Net Income TTM | $-254M | $-225M | · | $-223M | $-212M | $-205M | · | $-305M | $-263M | $-232M | · | $-22M | $-26M | $-30M | |
| Market Cap | $2.40B | $2.48B | · | $1.07B | $809M | $585M | · | $883M | $726M | $1.47B | · | $102M | $97M | $61M | |
| P/E | -8.3 | -9.2 | · | -4.2 | -3.2 | -2.2 | · | -1.8 | -1.6 | -3.3 | · | -4.6 | -3.6 | -2.0 | |
| P/S | · | 616.5 | · | 111.0 | 64.3 | 53.5 | · | 87.2 | 67.3 | 116.2 | · | · | · | · | |
| P/B | 4.6 | 4.2 | · | 4.1 | 3.0 | 1.9 | · | 4.1 | 2.9 | 5.2 | · | 16.8 | 10.3 | 4.4 | |
| P / Tangible Book | 4.6 | 4.2 | · | 4.1 | 3.0 | 1.9 | · | 4.1 | 2.9 | 5.2 | · | 16.8 | 10.3 | 4.4 | |
| P / Cash Flow | · | -42.2 | · | · | · | -11.0 | · | · | · | -131.9 | · | · | · | 2.5 | |
| Earnings Yield | -12.0% | -10.9% | · | -23.7% | -31.3% | -44.7% | · | -55.4% | -63.5% | -30.6% | · | -21.7% | -27.8% | -49.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $7M | $9M | $14M | · | · |
| Margen Operativo % | -3228.8% | -3382.4% | -781.4% | -738020.0% | 252040.0% |
| Beneficio neto | $-212M | $-293M | $-107M | $-37M | $-25M |
| EPS Diluido | $-2.43 | $-5.00 | $-5.38 | $-3.09 | $-2.14 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 14.7 | 4.1 | 6.6 | 3.1 | 5.8 |
| Ratio Rápido | 14.5 | 2.6 | 4.5 | 2.8 | 5.1 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-201M | $-118M | $-8M | $-29M | $-18M |
Propietarios institucionales (13F) 216 declarantes · $2.2B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
216
Valor en tenencia
$2.2B
Nuevas posiciones
30
Posiciones cerradas
27
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 30 (-22 vs trimestre anterior) | 27 (-1 vs trimestre anterior) | 75 (+1 vs trimestre anterior) | 63 (+15 vs trimestre anterior) | +81K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $359 966 248 | 16 987 553 | 16,40% | Acciones |
| BlackRock, Inc. | $186 588 376 | 8 805 492 | 8,50% | Acciones |
| VANGUARD GROUP INC | $129 705 133 | 6 038 414 | 5,91% | Acciones |
| STATE STREET CORP | $116 431 104 | 5 494 625 | 5,30% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $110 404 477 | 5 210 216 | 5,03% | Acciones |
| Redmile Group, LLC | $104 076 592 | 4 911 590 | 4,74% | Acciones |
| PRIMECAP MANAGEMENT CO/CA/ | $97 080 523 | 4 581 431 | 4,42% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $96 441 814 | 4 551 289 | 4,39% | Acciones |
| Driehaus Capital Management LLC | $92 094 685 | 4 346 139 | 4,20% | Acciones |
| ENAVATE SCIENCES GP, LLC | $76 576 401 | 3 613 799 | 3,49% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $58 387 674 | 2 754 889 | 2,66% | Acciones |
| MORGAN STANLEY | $51 024 322 | 2 407 942 | 2,32% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $42 740 421 | 2 017 009 | 1,95% | Acciones |
| JPMORGAN CHASE & CO | $38 989 792 | 1 848 548 | 1,78% | Acciones |
| Sofinnova Investments, Inc. | $36 453 496 | 1 720 316 | 1,66% | Acciones |
| READYSTATE ASSET MANAGEMENT LP | $34 027 326 | 1 605 820 | 1,55% | Acciones |
| GOLDMAN SACHS GROUP INC | $32 049 642 | 1 512 489 | 1,46% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28 584 865 | 1 348 979 | 1,30% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $28 550 515 | 1 347 358 | 1,30% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $26 493 328 | 1 250 275 | 1,21% | Acciones |
| Woodline Partners LP | $21 198 434 | 1 000 398 | 0,97% | Acciones |
| NORTHERN TRUST CORP | $20 519 253 | 968 346 | 0,93% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18 778 430 | 886 193 | 0,86% | Acciones |
| MetLife Investment Management, LLC | $18 203 820 | 859 076 | 0,83% | Acciones |
| JANUS HENDERSON GROUP PLC | $17 672 168 | 808 019 | 0,81% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $16 025 933 | 756 297 | 0,73% | Acciones |
| Pivotal bioVenture Partners Investment Advisor LLC | $15 521 929 | 732 512 | 0,71% | Acciones |
| TD Asset Management Inc | $15 241 374 | 719 272 | 0,69% | Acciones |
| NAN FUNG TRINITY (HK) LTD | $15 141 378 | 714 553 | 0,69% | Acciones |
| Candriam S.C.A. | $14 398 131 | 680 132 | 0,66% | Acciones |
| BANK OF AMERICA CORP /DE/ | $13 728 746 | 647 888 | 0,63% | Acciones |
| Parkman Healthcare Partners LLC | $12 591 140 | 594 202 | 0,57% | Acciones |
| MARSHALL WACE, LLP | $10 606 379 | 500 537 | 0,48% | Acciones |
| Qube Research & Technologies Ltd | $9 306 351 | 439 186 | 0,42% | Acciones |
| ALERUS FINANCIAL NA | $8 124 691 | 383 421 | 0,37% | Acciones |
| Granahan Investment Management, LLC | $8 021 305 | 378 542 | 0,37% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $7 796 866 | 367 967 | 0,36% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $7 623 738 | 359 780 | 0,35% | Acciones |
| Rock Springs Capital Management LP | $7 367 043 | 347 666 | 0,34% | Acciones |
| UBS Group AG | $6 960 767 | 328 493 | 0,32% | Acciones |
| Bank of New York Mellon Corp | $6 332 970 | 298 866 | 0,29% | Acciones |
| Atom Investors LP | $6 303 792 | 297 489 | 0,29% | Acciones |
| Nuveen, LLC | $6 122 258 | 288 922 | 0,28% | Acciones |
| KENNEDY CAPITAL MANAGEMENT LLC | $5 870 986 | 277 064 | 0,27% | Acciones |
| Atika Capital Management LLC | $5 570 851 | 262 900 | 0,25% | Acciones |
| FIRST TRUST ADVISORS LP | $5 569 219 | 262 823 | 0,25% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $5 320 851 | 251 102 | 0,24% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4 913 134 | 231 861 | 0,22% | Acciones |
| CITADEL ADVISORS LLC | $4 748 234 | 224 079 | 0,22% | Acciones |
| Burkehill Global Management, LP | $4 238 000 | 200 000 | 0,19% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Enavate Sciences GP, LLC, Immunome Aggregator, LP | 22 de diciembre de 2025 | 4,30% | Enmienda | · | SEC |
| Immunome Aggregator, LP, Enavate Sciences GP, LLC | 4 de febrero de 2025 | 6,00% | Enmienda | · | SEC |
| Arsenal Bridge Venture II, LLC, Arsenal Bridge Venture II-B, LLC, Arsenal Bridge Advisors, LLC, RBP Catalyst Fund, L.P., Research Bridge Partners, Inc., Isaac Barchas, James Graham ×2 presentaciones | 21 de agosto de 2024 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 12 de octubre de 2023 | · | Presentación inicial | Inversión pasiva | SEC |
| Morphimmune Inc. | 7 de julio de 2023 | · | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 27 insiders · 14 directivos · 14 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Clay B Siegall | President and CEO | 23 de julio de 2026 A | 870 704 | 4 | 0 | $1 749 659 |
| Purnanand D Sarma | President and CEO | 8 de junio de 2023 A | 10 500 | 0 | 0 | $0 |
| Max Rosett | Chief Financial Officer | 23 de julio de 2026 A | 101 287 | 0 | 3 | $-2 518 716 |
| Corleen M. Roche | Chief Financial Officer | 8 de junio de 2023 A | · | 0 | 0 | $0 |
| Richard F Fitzgerald | Chief Financial Officer | 1 de octubre de 2020 A | · | 0 | 0 | $0 |
| Jack Higgins | Chief Scientific Officer | 11 de septiembre de 2026 M | 56 250 | 0 | 2 | $-538 462 |
| Kinney Horn | CHIEF BUSINESS OFFICER | 4 de agosto de 2026 M | 0 | 0 | 2 | $-2 300 855 |
| Philip Tsai | Chief Technical Officer | 23 de julio de 2026 A | 81 550 | 1 | 0 | $204 900 |
| Robert Lechleider | Chief Medical Officer | 23 de julio de 2026 A | 69 805 | 0 | 5 | $-2 335 993 |
| Sandra G. Stoneman | CHIEF LEGAL OFFICER & GC | 23 de julio de 2026 A | 43 805 | 0 | 0 | $0 |
| Bruce Turner | Chief Strategy Officer | 9 de agosto de 2024 A | 42 300 | 0 | 0 | $0 |
| Phil Noland Roberts | Chief Technology Officer | 13 de diciembre de 2023 A | · | 0 | 0 | $0 |
| Matthew K Robinson | Chief Technology Officer | 8 de junio de 2023 A | · | 0 | 0 | $0 |
| Dennis H Giesing | Chief Development Officer | 8 de junio de 2023 A | · | 0 | 0 | $0 |
| Isaac Barchas | Consejero | 12 de agosto de 2026 S | 92 211 | 0 | 12 | $-18 274 988 |
| James P Boylan | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Sandra M Swain | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Philip Wagenheim | Consejero | 10 de junio de 2026 A | 341 147 | 0 | 2 | $-1 335 626 |
| Carol Schafer | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Jean Jacques Bienaime | Consejero | 10 de junio de 2026 A | 43 415 | 6 | 2 | $147 610 |
| Michael Rapp | Consejero | 2 de octubre de 2023 A | 1 071 172 | 0 | 0 | $0 |
| Franklyn G Prendergast | Consejero | 2 de octubre de 2023 A | 60 840 | 0 | 0 | $0 |
| Michael Lefenfeld | Consejero | 8 de junio de 2023 A | 40 747 | 0 | 0 | $0 |
| Richard A Baron | Consejero | 8 de junio de 2023 A | 2 343 | 0 | 0 | $0 |
| John L Lamattina | Consejero | 8 de junio de 2023 A | 66 953 | 0 | 0 | $0 |
| Michael Widlitz | Consejero | 28 de mayo de 2021 A | 51 315 | 0 | 0 | $0 |
| Wistar I Morris III | Propietario del 10% | 6 de octubre de 2020 C | 38 464 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 30 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,83% | 16 911 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,47% | 101 669 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,17% | 990 362 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 127 656 SH | 19 de agosto de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,13% | 1 389 NS | 31 de julio de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 113 000 SH | 19 de agosto de 2026 | Diario |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 26 776 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 2 695 157 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,08% | 50 465 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 606 588 SH | 19 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,06% | 67 982 SH | 11 de septiembre de 2026 | Diario |
| ISCG · iShares Trust | 0,05% | 17 382 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 43 948 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1 223 884 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,03% | 272 423 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,02% | 5 712 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,02% | 105 802 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 15 698 SH | 1 de octubre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,01% | 7 308 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4 072 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 31 476 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 145 382 SH | 11 de septiembre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 79 397 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 16 375 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 2 754 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 23 366 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 225 694 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8 523 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 4 411 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 9 397 SH | 11 de septiembre de 2026 | Diario |
IMNM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 20 analistas
COMPRA
Objetivo mediano
$36.00
+72,2%
5 25,0%
Compra fuerte
14 70,0%
Compra
1 5,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
14 analistas · 2026-09-29Objetivo medio $36.00 +72,2%
← Por Debajo de Todos los Objetivos
Precio Actual $20.90
Mín$30.00
Media$36.00
Máx$40.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | · |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026